0001752724-21-090814.txt : 20210511 0001752724-21-090814.hdr.sgml : 20210511 20210511095728 ACCESSION NUMBER: 0001752724-21-090814 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20210228 FILED AS OF DATE: 20210511 DATE AS OF CHANGE: 20210511 EFFECTIVENESS DATE: 20210511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FIDELITY CALIFORNIA MUNICIPAL TRUST CENTRAL INDEX KEY: 0000718891 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-03725 FILM NUMBER: 21909973 BUSINESS ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-563-7000 MAIL ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: FIDELITY CALIFORNIA TAX FREE FUND DATE OF NAME CHANGE: 19900618 FORMER COMPANY: FORMER CONFORMED NAME: FIDELITY CALIFORNIA TAX EXEMPT MONEY MARKET TRUST DATE OF NAME CHANGE: 19840408 0000718891 S000005447 Fidelity California Municipal Income Fund C000014848 Fidelity California Municipal Income Fund FCTFX C000014912 Fidelity Advisor California Municipal Income Fund: Class A FCMAX C000014914 Fidelity Advisor California Municipal Income Fund: Class C FCMKX C000014915 Fidelity Advisor California Municipal Income Fund: Class M FCMTX C000014916 Fidelity Advisor California Municipal Income Fund: Class I FCMQX C000205052 Fidelity Advisor California Municipal Income Fund: Class Z FIJBX 0000718891 S000005448 Fidelity California Limited Term Tax-Free Bond Fund C000014849 Fidelity California Limited Term Tax-Free Bond Fund FCSTX N-CEN 1 primary_doc.xml X0303 N-CEN LIVE 0000718891 XXXXXXXX 811-03725 true false false N-1A true Fidelity California Municipal Trust 811-03725 0000718891 OG5TD0IEISIU587N0981 245 Summer Street Boston 02210 US-MA US 1-800-FIDELITY Fidelity Service Company 245 Summer Street BOST 02210 1-800-FIDELITY Books and Records of the Fund as required to be maintained by the Investment Company Act N N N-1A 2 Y ELIZABETH ACTON N/A N MARIE KNOWLES N/A N JENNIFER TOOLIN MCAULIFFE N/A Y JOHN ENGLER N/A N MARK MURRAY N/A N ROBERT GARTLAND 001367184 N ANN DUNWOODY N/A N ABIGAIL JOHNSON 004340399 Y MICHAEL KENNEALLY 004140099 N ARTHUR JOHNSON N/A N KENNETH ROBINS 006242664 245 SUMMER STREET BOSTON 02210 XXXXXX Y N N N N N Fidelity Distributors Company LLC 8-35097 000017507 N/A Y N PricewaterhouseCoopers LLP 238 5493002GVO7EO8RNNS37 N N N N N N N Fidelity California Limited Term Tax-Free Bond Fund S000005448 CGZRC0U3V82YN7YY6O28 N 1 0 0 N/A Y N N N N/A 0.00000000 0.00000000 Rule 12d1-1 (17 CFR 270.12d1-1) Rule 17e-1 (17 CFR 270.17e-1) Rule 17a-7 (17 CFR 270.17a-7) Rule 32a-4 (17 CFR 270.32a-4) Y Y N N Fidelity Management & Research Company LLC 801-7884 000108281 5493001Z012YSB2A0K51 N FMR Investment Management (UK) Limited 801-28773 000108273 549300DJ0TLKPO1HIS84 Y GB N Fidelity Management & Research (Japan) Limited 801-69571 000148239 549300FF7J6H5TZ22Y05 Y JP N Fidelity Management & Research (Hong Kong) Limited 801-69507 000148045 549300VLVPR60I312N68 Y HK N Fidelity Investments Institutional Operations Company LLC 084-01839 549300XVSM8LN3LQOK63 Y N N INTERCONTINENTAL EXCHANGE INC 5493000F4ZO33MV32P92 N REFINITIV US HOLDINGS INC 549300NF240HXJO7N016 N N JPMorgan Chase Bank NA 7H6GLXDRUGQFU57RNE97 N Y Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) JPMORGAN CHASE BANK NA NEW YORK NY 7H6GLXDRUGQFU57RNE97 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) BANK OF NEW YORK MELLON HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) Y Fidelity Investments Institutional Operations Company LLC 549300XVSM8LN3LQOK63 Y N N Fidelity Service Company 549300LT256P1KNTYF28 Y N N 0.00000000 CITIGROUP INC N/A N/A 6SHGI4ZSSLCXXQSBB395 40600191.45000000 JEFFERIES GROUP LLC N/A N/A NY9Q8VBNB6D1L6YV0J84 8198605.55000000 DEUTSCHE BANK AG N/A N/A 7LTWFZYICNSX8D621K86 DE 43665000.00000000 ROYAL BANK OF CANADA N/A N/A ES7IP3U3RHIGC71XBU11 CA 5619267.40000000 MORGAN STANLEY N/A N/A IGJSJL3JD5P30I6NJZ34 76026567.55000000 GOLDMAN SACHS GROUP INC (THE) N/A N/A 784F5XWPLTWKTBV3E584 40705189.60000000 BARCLAYS PLC (UNGTD) N/A N/A 213800LBQA1Y9L22JB70 GB 31379626.60000000 JPMORGAN CHASE and CO N/A N/A 8I5DZWZKVSZI1NUHU748 35186427.90000000 BANK OF AMERICA CORPORATION N/A N/A 9DJT3UXIJIZJI4WXO774 50501386.40000000 WELLS FARGO and CO N/A N/A PBLD0EJDB5FWOLXP3B76 30856669.25000000 388741618.95000000 N 719688765.00000000 Uncommitted 400000000.00000000 N Uncommitted 1500000000.00000000 N Uncommitted 300000000.00000000 N Uncommitted 500000000.00000000 N Committed 4250000000.00000000 N Uncommitted 150000000.00000000 N Uncommitted 500000000.00000000 N Uncommitted 25000000.00000000 N N N N Fidelity California Municipal Income Fund S000005447 80THHSISENINCWS7L232 N 6 0 0 N/A N N N N N/A 0.00000000 0.00000000 Rule 17e-1 (17 CFR 270.17e-1) Rule 12d1-1 (17 CFR 270.12d1-1) Rule 22d-1 (17 CFR 270.22d-1) Rule 17a-7 (17 CFR 270.17a-7) Rule 32a-4 (17 CFR 270.32a-4) Y Y N N Fidelity Management & Research Company LLC 801-7884 000108281 5493001Z012YSB2A0K51 N FMR Investment Management (UK) Limited 801-28773 000108273 549300DJ0TLKPO1HIS84 Y GB N Fidelity Management & Research (Hong Kong) Limited 801-69507 000148045 549300VLVPR60I312N68 Y HK N Fidelity Management & Research (Japan) Limited 801-69571 000148239 549300FF7J6H5TZ22Y05 Y JP N Fidelity Investments Institutional Operations Company LLC 084-01839 549300XVSM8LN3LQOK63 Y N N BLOOMBERG LP 549300B56MD0ZC402L06 N INTERCONTINENTAL EXCHANGE INC 5493000F4ZO33MV32P92 N REFINITIV US HOLDINGS INC 549300NF240HXJO7N016 N N BANK OF NEW YORK MELLON HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) JPMORGAN CHASE BANK NA NEW YORK NY 7H6GLXDRUGQFU57RNE97 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) JPMorgan Chase Bank NA 7H6GLXDRUGQFU57RNE97 N Y Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) Y Fidelity Investments Institutional Operations Company LLC 549300XVSM8LN3LQOK63 Y N N Fidelity Service Company 549300LT256P1KNTYF28 Y N N 0.00000000 THE TORONTO DOMINION BANK N/A N/A PT3QB789TSUIDF371261 CA 32000000.00000000 DEUTSCHE BANK AG N/A N/A 7LTWFZYICNSX8D621K86 DE 94895623.00000000 BARCLAYS PLC (UNGTD) N/A N/A 213800LBQA1Y9L22JB70 GB 111530043.35000000 MORGAN STANLEY N/A N/A IGJSJL3JD5P30I6NJZ34 138087855.80000000 JPMORGAN CHASE and CO N/A N/A 8I5DZWZKVSZI1NUHU748 77787838.00000000 CITIGROUP INC N/A N/A 6SHGI4ZSSLCXXQSBB395 101272600.00000000 RAYMOND JAMES FINANCIAL INC. N/A N/A RGUZHJ05YTITL6D76949 21673594.40000000 WELLS FARGO and CO N/A N/A PBLD0EJDB5FWOLXP3B76 39164394.85000000 BANK OF AMERICA CORPORATION N/A N/A 9DJT3UXIJIZJI4WXO774 71724929.25000000 GOLDMAN SACHS GROUP INC (THE) N/A N/A 784F5XWPLTWKTBV3E584 29798662.20000000 802666147.30000000 N 2198020520.00000000 Uncommitted 400000000.00000000 N Uncommitted 25000000.00000000 N Uncommitted 500000000.00000000 N Uncommitted 150000000.00000000 N Committed 4250000000.00000000 N Uncommitted 1500000000.00000000 N Uncommitted 500000000.00000000 N Uncommitted 300000000.00000000 N N N N true INTERNAL CONTROL RPT 2 calimu_icr1.htm Converted by EDGARwiz

Report of Independent Registered Public Accounting Firm

To the Board of Trustees of Fidelity California Municipal Trust and Shareholders of Fidelity California Municipal Income Fund

In planning and performing our audits of the financial statements of Fidelity California Municipal Income Fund (one of the funds constituting Fidelity California Municipal Trust, hereafter referred to as the "Fund") as of and for the year ended February 28, 2021, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting.  Accordingly, we do not express an opinion on the effectiveness of the Fund's internal control over financial reporting.

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and trustees of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB.  However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities that we consider to be material weaknesses as defined above as of February 28, 2021.



This report is intended solely for the information and use of the Board of Trustees of Fidelity California Municipal Trust and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.



/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts

April 14, 2021



 INTERNAL CONTROL RPT 3 calimu_icr2.htm Converted by EDGARwiz

Report of Independent Registered Public Accounting Firm

To the Board of Trustees of Fidelity California Municipal Trust and Shareholders of Fidelity California Limited Term Tax-Free Bond Fund

In planning and performing our audits of the financial statements of Fidelity California Limited Term Tax-Free Bond Fund (one of the funds constituting Fidelity California Municipal Trust, hereafter referred to as the "Fund") as of and for the year ended February 28, 2021, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting.  Accordingly, we do not express an opinion on the effectiveness of the Fund's internal control over financial reporting.

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and trustees of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB.  However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities that we consider to be material weaknesses as defined above as of February 28, 2021.



This report is intended solely for the information and use of the Board of Trustees of Fidelity California Municipal Trust and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.



/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts

April 15, 2021